Seeking Alpha Notably, other drugs such as Keppra XR, Lamictal XR, and Carbatrol with 4%, 2%, and 2% of the carbamazepine market in their Y1, respectively, have performed much worse following launch. If we assume that strong sales of Oxtellar XR will similarly ...
SBWire (press release) The AED market is currently dominated by UCB's Keppra and GlaxoSmithKline's Lamictal . Although both drugs have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have ...
